Chemoinformaics analysis of HEX-2-ENOIC-ACID-METHYL-ESTER
| Molecular Weight | 1614.68 | nRot | 85 |
| Heavy Atom Molecular Weight | 1417.11 | nRig | 2 |
| Exact Molecular Weight | 1613.47 | nRing | 0 |
| Solubility: LogS | -6.816 | nHRing | 0 |
| Solubility: LogP | 7.746 | No. of Aliphatic Rings | 0 |
| Acid Count | 5 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 310 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 114 | No. of Aromatic Carbocycles | 0 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 196 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 102 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 310.655 |
| nHD | 5 | BPOL | 203.573 |
| QED | 0.183 |
| Synth | 2.071 |
| Natural Product Likeliness | 0.586 |
| NR-PPAR-gamma | 0.194 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.006 |
| HIA | 0.002 |
| CACO-2 | -4.69 |
| MDCK | 0.0000167 |
| BBB | 0.087 |
| PPB | 0.975421 |
| VDSS | 2.951 |
| FU | 0.0183866 |
| CYP1A2-inh | 0.712 |
| CYP1A2-sub | 0.178 |
| CYP2c19-inh | 0.479 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.349 |
| CYP2c9-sub | 0.942 |
| CYP2d6-inh | 0.293 |
| CYP2d6-sub | 0.066 |
| CYP3a4-inh | 0.447 |
| CYP3a4-sub | 0.06 |
| CL | 5.38 |
| T12 | 0.211 |
| hERG | 0.204 |
| Ames | 0.005 |
| ROA | 0.02 |
| SkinSen | 0.97 |
| Carcinogencity | 0.106 |
| EI | 0.96 |
| Respiratory | 0.641 |
| NR-Aromatase | 0.181 |
| Antiviral | Yes |
| Prediction | 0.574291 |